4.7 Article

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost

Related references

Note: Only part of the references are listed.
Article Immunology

Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy

Michela Sabbatucci et al.

Summary: The COVID-19 pandemic has had a significant impact on the Italian National Health System, leading to decreased routine childhood vaccine coverage rates. However, there has been an increase in chicken pox vaccination while recommended vaccinations have been moderately affected. Effective communication campaigns and educational programs are crucial to reinforce vaccination confidence and behavior during and beyond the COVID-19 era.

VACCINES (2022)

Editorial Material Psychology, Developmental

Lessons Learned From Human Papillomavirus Vaccination to Increase Uptake of Adolescent COVID-19 Vaccination Comment

Grace Ryan et al.

JOURNAL OF ADOLESCENT HEALTH (2022)

Article Public, Environmental & Occupational Health

HPV prevention and control-The way forward

Alex Vorsters et al.

Summary: The COVID-19 pandemic has created opportunities for HPV prevention and control, but also poses potential public health threats. Existing resources and experiences should be utilized to continue promoting HPV vaccination and testing to prevent HPV-related cancers.

PREVENTIVE MEDICINE (2022)

Article Economics

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data

A. Marcellusi et al.

Summary: This study aimed to estimate the lifetime risk of hospitalization associated with HPV-related diseases in Italy and evaluate the vaccination effect. Results showed a significant reduction in hospitalization risk for vaccinable females compared to nonvaccinable females before the age of 21, while no differences were found among males of the same birth cohort.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2021)

Article Public, Environmental & Occupational Health

Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers

Irene O. Aninye et al.

Summary: This report summarizes the discussions of the working group and identifies areas to address gaps in primary and secondary prevention approaches to improve access and health outcomes for women with HPV-related anogenital cancers.

JOURNAL OF WOMENS HEALTH (2021)

Article Immunology

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer

Supitcha Kamolratanakul et al.

Summary: Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15 HPV types related to various cancers. HPV vaccines have been proven to be safe and highly effective in preventing HPV infections and associated cancers, especially among young women. The different types of HPV vaccines have shown similar efficacy in protecting against certain HPV types, with the nonavalent vaccine offering additional protection against more types. HPV vaccination has also been shown to provide herd protection and reduce the prevalence of HPV-related cancers.

VACCINES (2021)

Article Public, Environmental & Occupational Health

Beliefs about HPV vaccination and awareness of vaccination status: Gender differences among Northern Italy adolescents

Laura Brunelli et al.

Summary: The study found that adolescents had insufficient knowledge about HPV vaccine, with a worrying proportion of them believing that HPV vaccine could prevent HIV/AIDS. Awareness about their vaccination status was poor, with more than half of them not involved in discussing HPV vaccine uptake. Girls outperformed boys in terms of knowledge, awareness, and engagement.

PREVENTIVE MEDICINE REPORTS (2021)

Review Public, Environmental & Occupational Health

The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis

Jiye Zhang et al.

Summary: The study demonstrates the efficacy of HPV vaccine in preventing HPV infections at the cervix, anal, and oral regions, with HPV 16/18 shown to be more effective in preventing anal and oral infections compared to HPV 6/11/16/18.

PUBLIC HEALTH (2021)

Article Public, Environmental & Occupational Health

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

Catherine de Martel et al.

LANCET GLOBAL HEALTH (2020)

Article Public, Environmental & Occupational Health

Awareness of HPV and drivers of HPV vaccine uptake among university students: A quantitative, cross-sectional study

Silvia Cocchio et al.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2020)

Article Biotechnology & Applied Microbiology

What is the most useful tool in HPV vaccine promotion? Results from an experimental study

Maria Rosaria Gualano et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Article Public, Environmental & Occupational Health

Strategies to achieve HPV-related disease control in Italy: results from an integrative approach

A Acampora et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2019)

Article Economics

Economic burden of HPV9-related diseases: a real-world cost analysis from Italy

F. S. Mennini et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)

Article Pharmacology & Pharmacy

Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study

Francesco Saverio Mennini et al.

CLINICAL DRUG INVESTIGATION (2018)

Review Public, Environmental & Occupational Health

Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence

C. Signorelli et al.

EPIDEMIOLOGY AND INFECTION (2017)

Article Public, Environmental & Occupational Health

Impact of HPV vaccination: health gains in the Italian female population

Andrea Marcellusi

POPULATION HEALTH METRICS (2017)

Editorial Material Infectious Diseases

Greatest effect of HPV vaccination from school-based programmes

David G. Regan et al.

LANCET INFECTIOUS DISEASES (2015)

Article Pediatrics

Immunogenicity and Safety of a 9-Valent HPV Vaccine

Pierre Van Damme et al.

PEDIATRICS (2015)

Article Immunology

Immunogenicity and safety of the 9-valent HPV vaccine in men

X. Castellsague et al.

VACCINE (2015)

Article Medicine, General & Internal

Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study

Francesco Saverio Mennini et al.

BMJ OPEN (2012)

Review Biochemistry & Molecular Biology

Papillomaviruses-to vaccination and beyond

H. zur Hausen

BIOCHEMISTRY-MOSCOW (2008)